Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06996626 · ClinicalTrials.gov registry record · NA

Real-time NOMA Evaluation

A NA study of Critical Illness, sponsored by David T Huang.

Recruiting
Registry status
NA
Development phase
3,000
Enrollment target
2
Study locations

NCT06996626 is a NA study of Critical Illness that is actively recruiting participants, run by David T Huang. The registered enrollment target is 3,000 participants, roughly in line with the 3,105-participant average among 91 other Critical Illness trials with a reported enrollment target. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06996626, a NA study of Critical Illness, is actively recruiting participants, sponsored by David T Huang.

RECRUITING
Registry status
NA
Development phase
3,000 participants
Enrollment target
2
Study locations

Study Summary

Alerts related to outlier clinician behavior are generated in real-time by an intelligent system continuously scraping EHR (electronic health record) data. These alerts are passed to the bedside and their potential impact on bedside clinical behavior is evaluated.

Conditions Studied

Interventions

  • DEVICE Revealed Alerts
  • DEVICE Unrevealed Alerts

Study Locations (2)

Pennsylvania

  • UPMC Montefiore - Pittsburgh
  • UPMC Presbyterian - Pittsburgh

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2025-06-23
Est. Completion 2027-06-30
Phase NA

Sponsor

David T Huang

1 total trials

What the Registry Record Tells You About NCT06996626

The ClinicalTrials.gov registry entry for NCT06996626 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 3,105-participant average among 91 other Critical Illness trials with a reported enrollment target. The listed sponsor is David T Huang, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Revealed Alerts is the first listed.

NCT06996626 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06996626 about?

NCT06996626 is a clinical study titled "Real-time NOMA Evaluation". Alerts related to outlier clinician behavior are generated in real-time by an intelligent system continuously scraping EHR (electronic health record) data. These alerts are passed to the bedside and their potential impact on bedside clinical behavior is evaluated.

What is the current status of trial NCT06996626?

This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2025-06-23. Estimated completion is 2027-06-30.

What conditions does trial NCT06996626 study?

This clinical trial studies the following conditions: Critical Illness.

What interventions are being tested in trial NCT06996626?

The interventions under investigation include: Revealed Alerts (DEVICE), Unrevealed Alerts (DEVICE).

Who is sponsoring clinical trial NCT06996626?

This trial is sponsored by David T Huang, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06996626 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.